APPL captures a wealth of data on plant characteristics with speed and precision, leveraging robotics, multi-modal imaging ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Lignans are low molecular weight polyphenolic compounds with important antitumor and antiviral properties. However, their low ...

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing the capabilities of its AI platform, GaluxDesign, in de novo antibody design.

Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation, adds: "Julia Vorholt's discoveries are groundbreaking. She has shown that microbes play a fundamental role in the survival of plants. Her ...

COPENHAGEN, Denmark, March 13, 2025 /PRNewswire/ -- Professor Julia Vorholt's work has changed how we think about plant health ... awarded by the Novo Nordisk Foundation. "Receiving this prize ...

Bagsværd, Denmark, 10 March 2025 – Today, Novo Nordisk announced headline results from REDEFINE 2, a phase 3 trial in the global REDEFINE programme. REDEFINE 2 is a 68-week efficacy and safety ...

Novo had an early lead on Lilly, with Wegovy reaching market before Lilly’s rival Zepbound and, at least so far, securing broader insurance coverage. But that early advantage may be dissipating.

Ever since a large-scale Spanish solar plant project resulted in the discovery ... “The sophistication of the defensive design and the need for a large workforce reinforce the idea of a ...

As part of its ongoing efforts to ensure patients who need Wegovy, or semaglutide, injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg can access it, Novo Nordisk (NVO) launched NovoCare Pharmacy ...